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Sialic acid catabolism drives intestinal inﬂammation
and microbial dysbiosis in mice
Yen-Lin Huang1, Christophe Chassard2,w, Martin Hausmann3, Mark von Itzstein4 & Thierry Hennet1
Rapid shifts in microbial composition frequently occur during intestinal inﬂammation, but the
mechanisms underlying such changes remain elusive. Here we demonstrate that an increased
caecal sialidase activity is critical in conferring a growth advantage for some bacteria
including Escherichia coli (E. coli) during intestinal inﬂammation in mice. This sialidase activity
originates among others from Bacteroides vulgatus, whose intestinal levels expand after
dextran sulphate sodium administration. Increased sialidase activity mediates the release of
sialic acid from intestinal tissue, which promotes the outgrowth of E. coli during inﬂammation.
The outburst of E. coli likely exacerbates the inﬂammatory response by stimulating the
production of pro-inﬂammatory cytokines by intestinal dendritic cells. Oral administration of a
sialidase inhibitor and low levels of intestinal a2,3-linked sialic acid decrease E. coli outgrowth
and the severity of colitis in mice. Regulation of sialic acid catabolism opens new perspectives
for the treatment of intestinal inﬂammation as manifested by E. coli dysbiosis.
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T
he intestinal microbiota has emerged as a key player in the
regulation of physiological pathways and in the develop-
ment of diseases. Along with intestinal diseases, such as
necrotizing enterocolitis1 and inﬂammatory bowel disease2, gut
microbiota contribute among others to the aetiology of diabetes3,
asthma4, autoimmunity5 and cancer6. Accordingly, much effort
has been dedicated in understanding the factors inﬂuencing the
composition of the intestinal microbiota to maintain or restore
health in the host organism.
Carbohydrates are a major class of food products that
profoundly affect the gut microbiota. Whereas most mono-
saccharides are absorbed by the small intestine, oligo- and
polysaccharides are not digested in the upper gastrointestinal
tract and reach the colon intact. The impact of complex
carbohydrates on microbial composition is based on the
expression of speciﬁc hydrolases7, which enable some bacterial
species to process and utilize breakdown products as nutrients,
thereby conferring a proliferative advantage over bacteria that
cannot process complex carbohydrates8. The ﬁrst carbohydrates
ingested just after birth are provided by breast milk, which is a
rich source of lactose and oligosaccharides9. The uptake of milk
oligosaccharides coincides with the microbial colonization of the
gut and favors the proliferation of bacteria equipped with
carbohydrate-processing enzymes, such as Biﬁdobacterium and
Bacteroides spp. that are enriched in breast-fed infants10.
In addition to food carbohydrates, several intestinal bacteria
can process host-derived carbohydrates, which are prominent
constituents of mucosal layers. Besides providing carbon sources
for bacterial growth, released host-derived carbohydrates
inﬂuence gene expression in the microbiota, thereby affecting
the virulence of pathogenic bacteria as demonstrated by the
regulation of virulence factors in enterohaemorrhagic Escherichia
coli by fucose11. Other host-derived carbohydrates, such as sialic
acids, are taken up by bacteria lacking de novo biosynthetic
pathways for these sugars, and incorporated into bacterial
capsule and lipooligosaccharides12. The decoration of bacterial
glycoconjugates with sialic acid protects microbes from
recognition by the host immune system13 and regulates the
host immune response through interactions with sialic acid-
binding lectins14. Finally, the interplay between intestinal
microbiota and host glycosylation is not limited to the
utilization of host glycans by bacteria. Sialic acids as terminal
residues on intestinal glycoconjugates are a prime target for
bacterial adhesins and toxins from Vibrio cholerae, Helicobacter
pylori and E. coli15,16.
The structural complexity of carbohydrates, either ingested in
the form of milk oligosaccharides or expressed as host-derived
glycans, hampers the elucidation of their impact on the gut
microbiota. Accordingly, little is known about the relevance of
speciﬁc carbohydrates on microbiota composition and on
intestinal physiology. The application of mice deﬁcient for
glycosyltransferases enables the investigation of interactions
between deﬁned carbohydrates, intestinal microbes and the host
immunity. For example, a study of a1,2-fucosyltransferase
Fut2 knockout mice has recently demonstrated the interplay
between fucosylated glycans and diet polysaccharides on shaping
the gut microbiota17. The study of a2,3 sialyltransferase St3gal4
knockout (ST) mice, which mediates a2,3-sialyllactose (3SL)
synthesis in mammary gland, has established the role of the
milk oligosaccharide on the gut microbiota and thereby on the
susceptibility of mice in dextran sulphate sodium (DSS)-induced
acute18 and chronic colitis19. Through the investigation of
DSS-mediated colitis in ST mice and the modulation of the
intestinal microbiota by selective antibiotic treatment, the present
study reveals the critical role of a2,3-linked sialic acid in
establishing a niche for intestinal E. coli after lactation and
during intestinal inﬂammation.
Results
Gut microbiota change during DSS-induced colitis. To unravel
the relationship between a2,3-linked sialic acid and the intestinal
microbiota, and to identify the mechanisms of a2,3-linked
sialic acid effects on colitis development, we have ﬁrst addressed
the impact of intestinal bacterial groups on colitis by treating
mice with a panel of antibiotics. Correlations between the
resulting changes in microbial composition and susceptibility to
DSS-mediated colitis pointed to speciﬁc bacterial families possibly
regulating the severity of colitis in wild-type (WT) and ST mice.
In fact, the composition of colonic bacteria in WT and ST mice
differed at the adult stage. The most abundant bacterial family in
WT mice was Ruminococcaceae, reaching 44% of total bacteria.
By contrast, Ruminococcaceae only represented 10% of colonic
bacteria in ST mice, whereas Porphyromonadaceae dominated by
reaching 37% (Fig. 1a). The bacterial composition of mice
undergoing intestinal inﬂammation induced by DSS changed
markedly, as seen by a strong expansion of Bacteroidaceae
and Enterobacteriaceae in WT mice. ST mice, which were
less susceptible to DSS than WT mice18, also showed
increased Bacteroidaceae levels during DSS challenge, whereas
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Figure 1 | Bacterial composition in mice with DSS-induced colitis. (a) 16S rRNA pyrosequencing analysis of faecal microbial taxa families in control
and DSS-treated WT and ST mice (at day 8 after DSS addition). (b) Pyrosequencing analysis of faecal microbial taxa at the genus level. Data show
the average percentage of total identiﬁed sequences obtained from a pool of eight mice per group. Only the bacterial taxa representing at least 1% of
total identiﬁed sequences are presented.
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Enterobacteriaceae remained at low level. Sequence analysis at the
genus level indicated that the Escherichia and Shigella accounted
for the observed increase of Enterobacteriaceae in WT mice, and
Bacteroides accounted for the increase of Bacteroidaceae in both
WT and ST mice under DSS challenge (Fig. 1b).
Antibiotics effect on DSS-induced colitis. To determine whether
a speciﬁc group of bacteria accounted for the different response to
DSS, we treated WT mice with a panel of antibiotics before DSS
challenge. Vancomycin, neomycin and penicillin exacerbated the
severity of DSS-induced colitis as monitored by loss of body
weight (Fig. 2a). Streptomycin was the only antibiotic that
attenuated the loss of body weight during colitis, whereas
chloramphenicol and metronidazole did not have much impact
on the course of the inﬂammatory response (Fig. 2a). To exclude
any damaging effect caused by the use of antibiotics on intestinal
barrier function, we assessed epithelial permeability by measuring
the leakage of orally administered ﬂuorescein isothiocyanate
(FITC)–dextran into the bloodstream. Permeability was only
signiﬁcantly increased after DSS ingestion, but not after antibiotic
treatment (Fig. 2b). We also tested the effect of a short-term
treatment with antibiotics to exclude possible adaptations of the
host mucosa to three weeks of altered microbiota composition.
Focusing on vancomycin (Fig. 2c) and streptomycin (Fig. 2d), we
could reproduce the worsening and improving effects of these two
antibiotics by only administering vancomycin and streptomycin
during DSS challenge. The protective effect of streptomycin
towards DSS challenge was even more pronounced in a short-
term treatment compared with a 3-week pre-treatment in both
WT and ST mice. The extent of intestinal inﬂammation was
conﬁrmed by measuring the length of the colon in treated mice.
The shortening of colon length induced by DSS ingestion was
aggravated by vancomycin and reduced by streptomycin (Fig. 2e).
The impact of vancomycin and streptomycin treatment on the
intestinal microbiota of WT mice was analysed by 16S rRNA
pyrosequencing and compared with the changes observed
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Figure 2 | Antibiotics effect on DSS-induced colitis. (a) Mice were treated with vancomycin (Van), neomycin (Neo), penicillin (Pen), streptomycin (Stp),
chloramphenicol (CAM) and metronidazole (Met) for 3 weeks before DSS challenge for 5 days. Body weight was measured by day 8 after initiation of DSS
challenge and given as percentage to the body weight of mice challenged with DSS without antibiotics. The data are represented as mean±s.e.m. N¼ 6–8,
*Po0.05 (two-tailed Student’s t-test). (b) Intestinal permeability was measured by FITC–dextran levels in the serum from control, colitogenic mice on day
5 of DSS challenge, and 3 weeks of antibiotic pretreated mice. N¼ 5, *Po0.05 (ANOVA, Bonferroni’s multiple comparison test). (c) Relative change in
body weight of WTand STmice treated with 0.5 g l 1 Van for 7 days and 3% DSS for 5 days; control mice received DSS without Van. (d) Relative change in
body weight of WT and ST mice treated with 1 g l 1 Stp for 8 days and 3% DSS for 5 days. (e) Colon length was determined at the end point of DSS
treatment. In (c–e) the data are represented as mean±s.e.m. from two independent experiments, N¼ 6-8, *Po0.05 (ANOVA, Bonferroni’s multiple
comparison test). (f) 16S rRNA pyrosequencing analysis of faecal microbial taxa families in untreated WT mice, in Van, Stp-treated WT mice and
DSS-challenged WTmice (WT–DSS). The data are represented as the percentage of total identiﬁed sequences obtained from a pool of eight mice
per group.
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during DSS challenge. Vancomycin induced a strong increase of
Enterobacteriaceae, which raised to 27% of total bacteria, whereas
Enterobacteriaceae remained below 0.1% of total bacteria in
streptomycin-treated mice (Fig. 2f). Under both antibiotics,
Bacteroidaceae expanded to represent the major bacterial family,
but the increase in Bacteroidaceae did not directly correlate with
the severity of DSS-induced colitis. In contrast, the abundance of
Enterobacteriaceae correlated with the magnitude of colitis.
Overgrowth of Enterobacteriaceae and several Bacteroidaceae spp.
during intestinal inﬂammation is well documented, although the
mechanisms underlying such expansions have not been identiﬁed
in previous studies20,21.
Expansion of E. coli during DSS-induced colitis. To verify
which species of Enterobacteriaceae expanded during intestinal
inﬂammation, we applied speciﬁc primers targeting the
b-glucuronidase uidA gene22 and conﬁrmed a signiﬁcant increase
of E. coli in DSS-challenged mice and in vancomycin-treated mice
(Fig. 3a). In contrast, a signiﬁcant reduction of E. coli was
observed in both WT and ST mice treated with streptomycin.
Overall, E. coli levels correlated with the severity of colitis in all
genotypes and antibiotic treatments tested. Of note, the level of
E. coli in adult ST mice was 2 orders of magnitude lower than in
WT mice, indicating that decreased exposure to a2,3-linked
sialic acid, because of reduced sialylation of host glycans and
the absence of 3SL in milk ingested during lactation, was
accompanied by low level of intestinal E. coli. The importance of
milk 3SL during lactation at promoting the low-level colonization
of E. coli was also visible in WT mice that were fostered by ST
mother during lactation. WT mice fed on 3SL-deﬁcient milk
(WTXF) showed lower E. coli levels than littermates fed on
normal milk. Similarly, ST mice fed on normal milk showed
elevated E. coli levels compared with littermates fed on 3SL-
deﬁcient milk (Fig. 3b). The relative abundance of intestinal
E. coli in cross-fostered mice also reﬂected the severity of
DSS-induced colitis18. Overall, these data conﬁrmed that neonatal
exposure to milk 3SL contributed to establishing an intestinal
niche for E. coli, thereby providing a ground for the subsequent
expansion of E. coli during colitis induced by DSS.
Exposure to sialic acid promotes E. coli expansion. To address
the impact of 3SL on E. coli proliferation, we isolated various
strains of commensal E. coli from the colon of WT mice during
DSS-induced colitis. The identity of the isolated bacteria with
E. coli was conﬁrmed by sequencing universal stress protein uspA
gene23, gyrase gyrB gene24 and by biochemical testing using the
API-20E Enterobacteriaceae detection system. The culture of the
isolated E. coli strain EHV2 in minimal medium containing
unique monosaccharides as carbon source conﬁrmed that
N-acetylneuraminic acid was a preferential source of energy for
E. coli (Fig. 4a). In contrast to free N-acetylneuraminic acid, the
milk oligosaccharides 3SL and a2,6-sialyllactose (6SL) did not
support E. coli growth in vitro (Fig. 4b). Proliferation could,
however, be restored by adding sterile-ﬁltered caecal ﬂuid from
WT mice to the culture medium, whereas E. coli growth was more
robust in 3SL than in 6SL containing minimal medium. Because
E. coli do not produce sialidases, the restoration of bacterial
growth pointed to the presence of an a2,3-preferential sialidase
activity in caecal ﬂuid. Such a sialidase activity was conﬁrmed
in caecal ﬂuid and shown to increase signiﬁcantly during
DSS-induced colitis in both WT and ST mice (Fig. 4c). The
substrate speciﬁcity of this caecal ﬂuid sialidase was demonstrated
by high-performance liquid chromatography (HPLC) analysis
after incubation of 3SL with caecal ﬂuid (Supplementary Fig. 1).
The sialidase activity was also increased in the caecal ﬂuid of WT
mice treated with streptomycin or vancomycin. By contrast, the
sialidase activity was strongly decreased in WT mice treated with
a broad-spectrum antibiotic cocktail consisting of ampicillin,
vancomycin, metronidazole and neomycin, which supported the
bacterial origin of the sialidase activity in caecal ﬂuid (Fig. 4d).
To identify the source of this sialidase activity, we focused
on bacterial groups, such as commensal Bacteroides and
Biﬁdobacteria species that are known to secrete sialidases25.
Host-derived sialidases were unlikely candidates since vertebrate
sialidases are unstable as soluble proteins in the extracellular
space26.
Bacteroides vulgatus sialidase releases sialic acid. As Bacteroides
species were strongly increased in the gut of mice challenged with
DSS (Fig. 1b) as well as in mice treated with streptomycin or
vancomycin (Fig. 2f), we searched for sialidase genes in the
caecum of DSS-challenged mice using a series of PCR primers
encompassing known Bacteroides sialidase sequences in the
glycoside hydrolase family 33 of the CAZy database. This analysis
revealed a 100-fold increase in copy number of the B. vulgatus
BVU_4143 sialidase gene (gene ID: 5305102) in WT mice treated
with DSS, whereas no change was detected in ST mice (Fig. 4e).
The low levels of BVU_4143 sialidase gene in ST mice, however,
shows that B. vulgatus is not the only source of sialidase activity
in these mice. The abundance of B. vulgatus also increased
accordingly in the colon of WT mice during DSS-induced
colitis (Supplementary Fig. 2). Moreover, the abundance of the
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Figure 3 | Intestinal E. coli in mice. Relative abundance of E. coli was determined by real-time PCR using speciﬁc uidA primers and quantiﬁed using
the 2nCt method. (a) Relative abundance of E. coli in groups of 6-week-old WT and ST mice treated with the antibiotics vancomycin (Van) and
streptomycin (Stp) and challenged with 3% DSS. Mice were treated for 8 days with or without antibiotics and DSS for the ﬁrst 5 days in drinking water.
Control mice received sterile drinking water. (b) Relative abundance of E. coli in 6-week-old WT, ST and respectively cross-fostered (XF) mice,
which were fed by foster mothers of the other genotype during lactation. The data are represented as median values. Each point indicates a single mouse
from two independent experiments. N¼ 6–8, *Po0.05 (ANOVA, Bonferroni’s multiple comparison test).
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BVU_4143 sialidase gene increased in WT mice treated with
streptomycin and vancomycin, but decreased in mice treated with
antibiotic cocktail (Fig. 4f).
The sialidase activity of BVU_4143 was conﬁrmed after
expression as a recombinant protein by demonstrating its ability
to hydrolyse the aryl substrate 4-methylumbelliferyl N-acetyl-
neuraminic acid (Supplementary Fig. 3a) and 2-O-(4-Nitrophe-
nyl) N-acetylneuraminic acid (Supplementary Fig. 3b). The
sialidase activity of recombinant BVU_4143 was inhibited by
the sialidase inhibitor N-acetyl-2,3-didehydro-2-deoxyneuraminic
acid (Neu5Ac2en) and lost by heat treatment. The addition of
recombinant BVU_4143 to minimal media containing 3SL or 6SL
enabled the growth of E. coli EHV2 on these oligosaccharides
(Supplementary Fig. 3c), as observed for the restoration of E. coli
EHV2 proliferation by addition of sterile-ﬁltered caecal ﬂuid to
culture medium containing 3SL and 6SL (Fig. 4b). Overall, these
results indicate that the expansion of B. vulgatus and the
concomitant increased sialidase activity during DSS-induced
colitis enables the sialic acid-dependent outgrowth of E. coli
during inﬂammation.
Sialic acid is required for sustaining E. coli colonization. The
dependence of E. coli on sialic acid in vivo was investigated by
deleting the sialic acid transporter nanT gene27. Disruption of
nanT, the ﬁrst committed step in the sialic acid utilization
pathway, abolished growth of the mutant E. coli strain in a sialic
acid-containing minimal medium, but not growth in glucose-
containing medium (Fig. 5a). By contrast, the disruption of
mannose transporter ManX did not affect the growth of E. coli in
both glucose and sialic acid-containing medium. To investigate
the in vivo colonization efﬁciency, nanT mutant and parental
E. coli were gavaged at equal amounts of each 106 cells
to ampicillin-pretreated mice. Colonization efﬁciency was
determined over a period of 10 days after inoculation by
counting E. coli isolated from freshly isolated faeces samples.
Both strains were colonized at 108–109 colony-forming units
(c.f.u.) per gram faeces in WT mice by 2 days after inoculation.
Parental E. coli remained stable over 10 days, but nanT mutants
decreased markedly over the same period (Fig. 5b). The same
experiment performed in ST mice showed that even parental
E. coli did not maintain their original levels in an environment
deﬁcient of a2,3-linked sialic acid (Fig. 5c). The comparison of
competitive index between parental and nanT E. coli in the
intestines of WT and ST mice suggested that the growth
advantage of parental E. coli was associated with the local
availability of sialic acid (Fig. 5d). The levels of free Neu5Ac in the
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Figure 4 | Sialic acid processing and uptake by E. coli in vitro. (a) Growth of E. coli EHV2 in M9 minimal medium containing single monosaccharide at
10mM. Sia, N-acetylneuraminic acid; Glc, glucose; GlcNAc, N-acetylglucosamine; GalNAc, N-acetylgalactosamine; Gal, galactose; Fuc, fucose. (b) Growth
of E. coli in minimal medium containing 5mM of 3SL and 6SL with and without supplementation of caecal ﬂuid (CF, 1.5%, v/v) derived from WTmice.
(c) CF of conventional and DSS-challenged WT and STmice were collected. Sialidase activity was determined by measuring ﬂuorescent 4-MU-NeuNAc
at 440nm. (d) Sialidase activity was also measured in the CF of WT and WTmice treated with either streptomycin (Stp 1 g l 1), vancomycin (Van
0.5 g l 1) or antibiotic cocktail (AVMN: ampicillin, Van, metronidazole and neomycin). In (c–d), the data are represented as mean±s.e.m. from two
independent experiments, N¼ 5–8, *Po0.05 (two-tailed Student’s t-test). (e) The abundance of the B. vulgatus BVU_4143 sialidase gene was determined
by real-time PCR from caecum samples of WTand STmice, and (f) caecum samples of antibiotic-treated WTmice. The data are represented as gene copy
number per mg of faecal DNA. In (e–f) each data point indicates a single mouse from two independent experiments, N¼ 5–7, *Po0.05 (two-tailed
Student’s t-test).
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caecal ﬂuid were indeed higher in WT mice than in ST mice
(Fig. 5e), thereby correlating with the occurrence of intestinal
E. coli in WT and ST mice (Fig. 3a). The concentrations of
Neu5Ac measured in the caecum of WT mice treated with
streptomycin and vancomycin (Fig. 5f) also matched the
abundance of E. coli in these mice (Fig. 3a), but the low levels
of Neu5Ac in streptomycin-treated mice also indicated that other
bacteria consumed this carbohydrate when E. coli was suppressed.
In fact streptomycin treatment increased the abundance of
Bacteroidaceae and Porphyromonadaceae (Fig. 2f) that include
several sialidase producers and sialic acid consumers, such as
Bacteroides fragilis and Parabacteroides distasonis. In the late
stage of DSS-induced colitis, the levels of free Neu5Ac decreased
in WT mice and relatively increased in ST mice, which reﬂected
increased sialic acid usage by E. coli and increased sialidase
activity (Fig. 4c) during intestinal inﬂammation. Accordingly,
these results were consistent with the hypothesis that E. coli
outgrowth in the intestine depends on the release of sialic acid
from host glycans.
Sialidase inhibition lowers E. coli expansion and colitis. On the
basis of the requirement for sialidase activity to cleave a2,3-linked
sialic acid and to promote E. coli proliferation during intestinal
inﬂammation, we hypothesized that sialidase inhibition would
decrease both the expansion of E. coli during DSS-induced colitis
and the severity of the inﬂammatory response. We ﬁrst conﬁrmed
the effectiveness of the sialidase inhibitor Neu5Ac2en at pre-
venting E. coli growth in presence of 3SL and caecal ﬂuid in vitro
(Fig. 6a). Next, we conﬁrmed the effectiveness of Neu5Ac2en at
reducing the release of sialic acid in vivo by showing decreased
levels of free Neu5Ac in the caecum of WT mice treated with the
sialidase inhibitor (Fig. 6b). Oral administration of Neu5Ac2en to
WT mice during DSS challenge also prevented the outgrowth of
E. coli during inﬂammation, as seen by a decrease of E. coli levels
by 2–3 orders of magnitude (Fig. 6c), and decreased the severity
of DSS-induced colitis as assessed by change in body weight
(Fig. 6d) and colon length (Fig. 6e). Neu5Ac2en treatment also
reduced the loss of colonic architecture and leukocyte inﬁltration
(Fig. 6f), although without reaching statistical signiﬁcance
(Fig. 6g). Neu5Ac2en treatment was by contrast ineffective in ST
mice challenged with DSS (Supplementary Fig. 4), which was
expected considering the low levels of sialidase-producing
Bacteroides spp. and low sialidase activity in the caecum of ST
mice. Overall, these data demonstrated that inhibition of caecal
sialidase activity signiﬁcantly reduced the outburst of E. coli and
hence the severity of colitis in mice.
E. coli intensiﬁes dendritic cell activation. The question as
to how E. coli proliferation affected intestinal inﬂammation
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remained open. We therefore assessed the pro-inﬂammatory
potential of E. coli on intestinal CD11cþ dendritic cells (DCs).
Previous work has shown increased CD11cþ DC inﬁltration to
the colonic mucosa of WT mice compared with ST mice, sug-
gesting a critical role of DCs during intestinal inﬂammation19.
We examined the stimulatory effect of E. coli EHV2 and of the
Bacteroides thetaiotaomicron on mesenteric lymph node-derived
CD11cþ DCs. B. thetaiotaomicron was chosen as reference
because Bacteroides represents a major group of intestinal
bacteria, which expanded in both WT and ST mice during
DSS-mediated colitis (Fig. 1b). Stimulation of CD11cþ DCs with
ﬁxed E. coli increased the expression of the activation markers
major histocompatibility complex (MHC)-II, CD86 and CD40,
whereas stimulation with ﬁxed B. thetaiotaomicron failed to
activate CD11cþ DCs (Fig. 7a). The pro-inﬂammatory effect of
E. coli was not limited to mouse DCs as stimulation of the human
monocytic cell line THP-1 also increased the expression of the
activation marker CD54 (Fig. 7b). The effect of E. coli was
even more pronounced when measuring the secretion of pro-
inﬂammatory cytokines from stimulated mouse CD11cþ DCs.
The levels of interleukin (IL)-6, tumour-necrosis factor (TNF)-a
and IL-12p40 produced after E. coli stimulation exceeded those
reached after stimulation with lipopolysaccharides (LPSs) at
500 ngml 1. Under identical conditions, B. thetaiotaomicron did
not increase cytokines production (Fig. 7c).
Overall, this study demonstrated that the expansion of
commensal E. coli following the alteration of epithelial integrity
caused by DSS uptake was mediated by increased exposure to
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sialic acid, and that overgrowth of E. coli exacerbated intestinal
inﬂammation by stimulating the release of pro-inﬂammatory
cytokines from intestinal DCs.
Discussion
Multiple studies have documented that intestinal inﬂammation is
frequently accompanied by imbalanced microbiota. Such a
dysbiosis is often characterized by a relative increase of facultative
anaerobic Enterobacteriaceae28. Different factors such as nitrate29
and enterobactin30 promote Enterobacteriaceae expansion. The
present study underlines the contribution of host glycosylation,
speciﬁcally of a2,3-linked sialic acids, in enabling the proliferation
of Enterobacteriaceae during intestinal inﬂammation in mice.
Exposure to a2,3-linked sialic acids begins during lactation with
the uptake of the milk oligosaccharide 3SL. After weaning,
sialylated host glycans constitute the main source for the
carbohydrate. Whereas, Enterobacteriaceae genomes encode
various glycosidases, bacteria such as E. coli cannot digest
sialylated oligosaccharides. Therefore, their growth relies on
scavenging free monosaccharides released by glycosidases of
other bacteria. Our comparative study of monosaccharides
showed that the sialic acid yielded the fastest growth of E. coli
among the main monosaccharides encountered in mammalian
glycans. This ﬁnding is consistent with previous work showing
that sialic acid catabolism conferred a growth advantage to
intestinal E. coli31,32.
The growth advantage provided by sialic acid was dependent
on a sialidase displaying a preference for a2,3-linked over
a2,6-linked sialic acids, and which increased during intestinal
inﬂammation. Commensal E. coli do not express sialidases to
liberate host sialylated glycans, therefore the access to bound
sialic acids depends on secreted sialidases, such as the BVU_4143
sialidase identiﬁed in our study. We also detected other sialidase
genes in colitogenic mice, such as sequences sharing similarity
with sialidase genes encoded by B. fragilis and P. distasonis,
although the abundance of these sialidase sequences did not vary
between mouse genotypes and during DSS-mediated colitis.
The dependence of E. coli on sialidases secreted by Bacteroides
spp. may explain the parallel increased abundance of Bacteroides
spp. and E. coli observed in patients with colitis33. A recent study
also demonstrated that the commensal sialidase-producing
B. thetaiotaomicron was associated with proliferation of
Salmonella enterica typhimurium and Clostridium difﬁcile34. By
contrast, colonization of mice with a sialidase-deﬁcient mutant
reduced free sialic acid levels and thereby impaired the expansion
of C. difﬁcile.
The decreased severity of DSS-induced colitis in mice treated
with sialidase inhibitor demonstrated the contribution of sialic
acid in E. coli expansion and in the ensuing inﬂammatory
response. Administration of free sialic acid to mice before or
during DSS challenge, however, failed to affect the levels of
intestinal E. coli and the severity of colitis (Supplementary Fig. 5).
Considering that monosaccharides are absorbed in the small
intestine and only minute amounts reach the colon, oral
supplementation with sialic acid is thus unlikely to inﬂuence
the outgrowth of E. coli in the colon. Therefore, the release of
sialic acid from host glycans is critical in promoting the growth
advantage of E. coli. The increase in sialylation of intestinal
mucins during colitis35,36 likely facilitates the local release of free
sialic acid during inﬂammation.
Our ﬁndings showed that commensal E. coli was a potent
activator of a pro-inﬂammatory response in intestinal DCs. The
activation of DCs was likely induced by surface LPSs triggering
Toll-like receptor-4 signalling. The strong pyrogenic effect of
commensal E. coli over the one induced by B. thetaiotaomicron
matches previous ﬁndings showing that E. coli LPS was more
active than Bacteroides spp.-derived LPS at inducing TNF-a
production37. Similar differences in pyrogenicity were also noted
in mouse models38,39. These results demonstrate that increased
E. coli levels likely exacerbate inﬂammation through activation of
mucosal immune cells such as DCs. Several intestinal bacteria
regulate mucosal immunity, thereby affecting the occurrence of
Th17 cells in the lamina propria in the case of segmented
ﬁlamentous bacteria40,41, or the induction of Foxp3þ Treg cells
in the case of a group of Clostridium spp.42 and B. fragilis43.
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We cannot exclude that the disappearance of inﬂammation-
lessening bacteria also affects the severity of colitis alongside the
expansion of pro-inﬂammatory E. coli, but such contributions are
unlikely since we failed to detect any differences in the
distribution and amounts of mucosal immune cells between
WT and ST mice before DSS-induced colitis18. Therefore, we
conclude that the proliferation of E. coli supported by a2,3-linked
sialic acids was the main factor regulating the magnitude of
intestinal inﬂammation triggered by DSS ingestion.
This study demonstrated the critical role of a2,3-linked sialic
acids provided by milk-derived 3SL during lactation and by host
mucosal glycans in establishing an intestinal niche for E. coli in
mice. Expansion of E. coli during colitis directly depended on
sialic acid release from host glycans after sialidase activity.
This resulting overgrowth of E. coli leads to exacerbation of the
pro-inﬂammatory response by intestinal DCs. The beneﬁcial
outcome of sialidase inhibition on the severity of DSS-induced
colitis suggests that sialidase inhibitors should be investigated as
agents able to reduce intestinal inﬂammation by preventing
dysbiosis manifested by Enterobacteriaceae expansion.
Methods
Bacterial DNA extraction and quantitative PCR. DNA was isolated from faecal
samples using the QIAamp DNA stool mini kit (Qiagen) according to manu-
facturer’s instructions. Lysis temperature was increased to 95 C for 5min to ensure
complete cell lysis of Gram-positive cells. The proportion of bacterial family and
genera in faecal samples were determined by real-time PCR using the EvaGreen
qPCR Master Mix (Biotium). Cycling conditions were 40 cycles at 95 C for 10 s,
60 C for 10 s and 72 C for 25 s after an initial denaturation at 95 C for 3min.
Primer pairs speciﬁc for 16S rRNA of Bacteroidetes (Bac32F: 50-AACGCTAGCTA
CAGGCTT-30, Bac303R: 50-CCAATGTGGGGGACCTTC-30); Enterobacteriaceae
(Eco1457F: 50-CATTGACGTTACCCGCAGAAGAAGC-30 , Eco1652R: 50-CTCTA
CGAGACTCAAGCTTGC-30); and total bacteria (Eub338F: 50-ACTCCTACGGG
AGGCAGCAG-30 , Eub518R: 50-ATTACCGCGGCTGCTGG-30) were described
previously44,45. Primers (UAL1939b: 50-ATGGAATTTCGCCGATTTTGC-30 ,
UAL2105b: 50-ATTGTTTGCCTCCCTGCTGC-30) targeting b-glucuronidase uidA
gene was used to evaluate the relative abundance of E. coli22. Quantiﬁcation values
were calculated by the 2nCt method relative to total bacterial 16S rRNA
amplicons46.
16S rRNA pyrosequencing. Faecal DNA was isolated from fresh stool samples of
7-week-old WT and ST male mice before and at day 8 after initiation of DSS
treatment. The 16S rRNA V5–V6 region was ampliﬁed from faecal DNA samples
using primer 784F and 1061R47. Amplicons were sequenced using a Roche 454
GS-FLX system (DNAVision, Belgium). The QIIME software was used for
taxonomic classiﬁcation. Taxonomy was assigned using Ribosomal Database
Project (RDP) classiﬁer and the Greengenes database48. Bacterial diversity was
determined at the phylum, family and genus levels. The sequencing reads have
been deposited in the NCBI sequence read archive SRA as Bioproject
PRJNA289738.
Mouse models. WT and sialyltransferase St3gal4 / mice49 were of C57BL/6
background and derived from the same breed and maintained in light-cycled and
climate-controlled facility. Animals were received regular laboratory chow diet
(KLIBA extrudat no. 3436, Provimi Kliba, SA, Switzerland) and sterile water ad
libitum. Synchronized matings were set up for WT and ST mice to allow the
exchange of newborn mice for cross-fostering experiments. All experiments were
performed in compliance with the Swiss Animal Protection Ordinance and
approved by the Veterinary Ofﬁce of the Canton of Zurich, Switzerland.
Antibiotic treatment and DSS-induced colitis. Six- to 7-week-old male mice
were treated with 3–3.5% (w/v) DSS (molecular weight¼ 36–50 kDa; MP
Biomedicals) in drinking water for 5 days, followed by a supply of normal water
until sacriﬁce of the animals. Body weight and physical activity were monitored
daily. For long-term antibiotic treatment, 3-week-old mice were provided with
sterile drinking water supplemented with vancomycin (0.5 g l 1), streptomycin
(1 g l 1), neomycin (1 g l 1), chloramphenicol (0.5 g l 1) or metronidazole
(1 g l 1) plus aspartame (0.25%, w/v) for 3 weeks before the beginning of DSS
treatment. For short-term antibiotic treatment, mice were administered sterile
drinking water supplemented with vancomycin (0.5 g l 1) or streptomycin
(1 g l 1) for 8 days, during which they also received 3% of DSS on the ﬁrst 5 days.
Transepithelial permeability assay. Mice were gavaged with 600mg kg 1 body
weight of FITC–dextran (MW 3000–5000, Sigma-Aldrich) and whole blood was
collected by cardiac puncture 4 h after gavage. Blood serum was collected after
centrifugation at 1500g for 10min. Serum ﬂuorescence intensity was measured
using a multi-detection microplate reader (Tecan Inﬁnite M200 Pro, Switzerland)
with an excitation wavelength of 485 nm and an emission wavelength of 535 nm.
FITC concentration (mgml 1) was calculated from a standard curve using serial
dilutions of FITC–dextran50.
Bacterial strains and mutant construct. E. coli strain EHV2 was isolated from
inﬂamed colon surface of DSS-treated C57/BL6 mice. The isolate strain was
conﬁrmed by 16S rRNA sequencing, universal stress protein uspA23, gyrase gyrB24
sequencing and phenotypic analysis (API-20E Enterobacteriaceae identiﬁcation kit;
bioMerieux). E. coli strain HS996 was obtained from Genebridge and transformed
with pET16b vector containing an ampicillin resistance gene. HS996-nanT
knockout mutant was constructed by introducing a kanamycin-resistance cassette
by homologous recombination into the nanT locus with followed by manufacture’s
instruction (Genebridge, Germany). The genomic primers used for the targeting
construct were designed according to the ﬂanking regions of the E. coli nanT gene:
forward primer f182 was 50-ATACCAAAGCGTGTGGGCATCGCCCACCGCG
GGAGACTCACAATGAGTACAATTAACCCTCACTAAAGGGCG-30 , and
reverse primer r1723 was 50-GCAACAGGATTAACTTTTGGTTTTGACTAAAT
CGTTTTTGGCGCTGCCAATAATACGACTCACTATAGGGCTC-30 . Null
mutation at the nanT locus was conﬁrmed by genome sequencing and growth
phenotype. B. thetaiotaomicron (DSM 2079T) was obtained from the German
Collection of Microorganisms and Cell Cultures (Braunschweig, Germany).
Cells were grown in YCFA (yeast extract-casein hydrolysate-fatty acids) medium
containing volatile fatty acids51 at 37 C anaerobically in rubber-sealed Hungate
tubes. Cell density was measured by a spectrophotometer at 600 nm (S2100 Diode
array, Biochrom WPA).
Carbohydrate metabolism assay. E. coli EHV2 (107 cells) were cultured in 3ml
of M9 minimal medium52 containing 10mM of either glucose (Glc), galactose
(Gal), N-acetylglucosamine (GlcNAc), N-acetylgalactosamine (GalNAc), fucose
(Fuc) and N-acetylneuraminic acid (Sia) as single carbohydrate source at 37 C for
24 h. The milk oligosaccharides 3SL and 6SL were tested as 5mM in 3ml of
M9 minimal medium supplemented with PBS or sterile-ﬁltered mouse caecal ﬂuid
(1.5%, v/v). All neutral monosaccharides were purchased from Sigma-Aldrich
except N-acetylneuraminic acid from Carbosynth (Berkshire, UK). The
oligosaccharides 3SL and 6SL were obtained from Glycom A/S (Lyngby, Denmark).
Cell density was determined by OD 600 values at 3, 6, 12 and 24 h. For
determination of the growth phenotype in nanT mutant and ManX mutant,
parental and mutant strains were cultured in modiﬁed M9 minimal medium
(additional 0.003% L-histidine, 0.004% leucine and 0.01% yeast extract)
containing 10mM of glucose or N-acetylneuraminic acid.
Sialidase activity assay. Mouse caecal content was collected and centrifuged at
15,000g for 10min at 4 C. The supernatant was ﬁltered through a 0.45-mm
membrane to yield caecal ﬂuid. The ﬂuorogenic substrate 20-(4-methylumbelliferyl)-
a-D-N-acetylneuraminic acid sodium salt (4-MU-NeuNAc; Carbosynth) was used
to determine sialidase activity. In brief, caecal ﬂuid (10%, v/v) was incubated with
0.1mM 4-MU-NeuNAc in 0.2ml of 100mM sodium acetate buffer (pH 7.4) at
37 C for 15min. Assays were stopped by adding 0.8ml of 0.5M sodium carbonate
buffer (pH 10.5) and further diluted 20-fold before ﬂuorescence measurement.
Cleaved 4-methylumbelliferone (4-MU) was measured by ﬂuorescence detection in
a multi-detection microplate reader at an excitation wavelength of 360 nm and an
emission wavelength of 440 nm (ref. 53).
Quantitative PCR of bacterial sialidase genes. Sequences of sialidase (EC
3.2.1.18) genes from Bacteroidaceae were retrieved from the GH33 sialidase family
of the CAZy database. Primers encompassing conserved DNA stretches of sialidase
genes from P. distasonis, B. vulgatus, B. thetaiotaomicron and B. fragilis were
designed based on multiple alignment analysis. The lack of signiﬁcant sequence
similarity of the selected primers with unrelated bacterial sequences was conﬁrmed
by BLAST analysis. The B. vulgatus sialidase primers used for quantitative PCR
analysis were Bv-f266: 50-GGAGGGGAAAGACTTATTTTGC-30 , Bv-r501: 50-TTC
CACCACTTCTGCCGAC-30 ; cycling conditions were 40 cycles at 95 C for 10 s,
60 C for 10 s and 72 C for 25 s after an initial denaturation at 95 C for 3min.
Quantiﬁcation values are represented as gene copy numbers per mg of total
faecal DNA.
Molecular cloning and puriﬁcation of sialidase. The gene encoding
B. vulgatus_4143 sialidase (Gene ID: 5305102) was ampliﬁed by PCR using the
genomic DNA from caecum sample in WT–DSS mouse as template. NdeI and
BamHI sites were introduced in the forward Bvu_4143F 50-GGCCATATGAGA
AACCCTAGCTTATTA-30 and reverse primer Bvu_4143R: 50- GCGGGATCC
TTATTTGGTCTTAATAAT-30 , respectively. PCR conditions were thirty cycles of
30 s at 95 C, 30 s at 53 C, 3.5min at 72 C. The PCR product was digested with
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NdeI and BamHI and subcloned into the pET16b expression vector (Novagen).
The pET16b- BVU_4143 vector was transformed into E. coli BL21-star (DE3) cells
(Invitrogen) cultured in LB broth and supplemented with ampicillin (100 mgml 1)
at 37 C. On reaching an OD 600 value of 0.5, BVU_4143 expression was induced
by adding 0.5mM Isopropyl b-D-1-thiogalactopyranoside and incubating bacteria
at 30 C for 5 h. Bacteria were then resuspended in 100mM Tris-HCl plus 20mM
imidazole (pH 7.4) and disrupted by sonication. The resulting cell extract was
incubated with Ni-sepharose (GE Healthcare Life Sciences) at 4 C overnight,
washed with 100mM Tris-HCl containing 40mM imidazole and the His6-tagged
BVU_4143 sialidase was eluted with 500mM imidazole.
Bacterial colonization ﬁtness assay. The relative ﬁtness of E. coli strains
for colonization of the mouse intestine was monitored as described34. Brieﬂy,
6-week-old WT mice were given drinking water containing ampicillin (2mgml 1)
for 2 days before gavage with 106 c.f.u. of parental HS996-ampr and HS996-nanT
mutant::Kanar E. coli. Fresh faecal samples were collected, serially diluted and
plated on LB agar containing ampicillin (100 mgml 1) or ampicillin plus
kanamycin (30mgml 1) by days 1, 2, 5 and 10 after gavage. Competitive index
was calculated as the ratio of parental to nanT mutant E. coli.
Quantiﬁcation of caecal sialic acids. Mouse caecal content (B500mg) was
weighed out and centrifuged for 10min at 16,000g at 4 C. The supernant was
collected and ﬁltered through 0.45 mm cronus HPLC membrane to get caecal ﬂuid
and stored at  20 C before use. Caecal ﬂuid was derivatized with 1,2-diamino-
4,5-methylene-dioxybezene (DMB; Sigma-Aldrich) as described previously54.
In brief, 10ml of caecal ﬂuid was incubated with 200ml of the DMB solution at
50 C for 2.5 h in the dark. DMB solution was prepared by dissolving DMB
dihydrochloride (7mM) in 1.4M acetic acid containing 0.75M b-mercaptoethanol
and 18mM sodium hydrosulﬁte. The reaction was stopped by adding 800 ml of
ice-cold distilled water. The derivatized product was analysed by reverse-phase
HPLC using a ODS Hypersil 150  3mm column (Thermo scientiﬁc). The mobile
phase was acetonitrile/methanol/water (9:7:84, v/v) at a ﬂow rate of 0.3mlmin 1.
Florescence of the derivatized product was monitored at 373 nm (excitation) and
448 nm (emission). DMB-derivatized Neu5Ac was identiﬁed by comparison with
authentic sialic acid standards.
Sialidase inhibition. The sialidase inhibitor N-acetyl-2,3-didehydro-2-
deoxyneuraminic acid (Neu5Ac2en) was prepared in house based on published
procedures55. For in vitro inhibition, E. coli EHV2 was cultured for 24 h at 37 C in
M9 minimal media containing 5mM 3SL, caecal ﬂuid (1.5%, v/v) and varying
Neu5Ac2en concentrations. For in vivo inhibition, mice were anesthetized by
isoﬂurane inhalation, gavaged with 300 ml of Neu5Ac2en (10mg kg 1 per day) in
sterile saline at days 0, 1, 2 and 5 of DSS challenge. Control groups received sterile
saline.
Histological staining of colonic tissue. Distal colons were removed, cut
longitudinally, and ﬁxed in 10% neutral buffered formalin then embedded in
parafﬁn. Tissue samples were cut in serial 5-mm sections, which were stained with
hematoxylin-eosin (Sigma-Aldrich). Histological sections were examined by using
microscope Zeiss Axio Imager.Z2, objective Zeiss EC Plan Neoﬂuar 10 /0.3.
Image was acquired by Zeiss AxioCam HrC camera and analysed with Zeiss
AxioVision software (AxioVs40V4.8.2.0). Sections were scored individually by an
independent investigator blinded to the type of treatment. Morphological changes
and leukocyte inﬁltration in the colon were scored as previously described56.
Histology was scored as follows: epithelium 0: normal morphology; 1: loss of goblet
cells; 2: loss of goblet cells in large areas; 3: loss of crypts; and 4: loss of crypts in
large areas. Inﬁltration 0: no inﬁltrate; 1: inﬁltrate around crypt basis; 2: inﬁltrate
reaching to lamina muscularis mucosae; 3: extensive inﬁltration reaching the
lamina muscularis mucosae and thickening of the mucosa with abundant oedema;
and 4: inﬁltration of the lamina submucosa. The total score represents the sum of
the epithelium and inﬁltration score.
DC Isolation and stimulation. Mesenteric lymph nodes were isolated and
incubated in 2.5mgml 1of collagenase type D (Roche) in RPMI 1640 containing
10% FCS for 10min at 37 C. Tissues were gently homogenized by passing through
an 18-gauge needle, then incubated for 30min at 37 C. The resulting cell
suspensions were ﬁltered through 40-mm cell strainers and incubated with
Fc-blocker (anti-CD16/32; eBioscience) for 10min. CD11cþ cells were isolated
with anti-CD11c MicroBeads (Miltenyi Biotec) according to the manufacturer’s
instructions. CD11cþ DCs (2 105 cells per ml) were culture in RPMI 1640
containing 10% FCS, and stimulated with ﬁxed bacteria or PBS for 14 h at 37 C.
E. coli (EHV2) and B. thetaiotaomicron (DSMZ 2079T) were ﬁxed in 0.5%
paraformaldehyde for 15min at room temperature and washed with PBS before
stimulation. Fixed bacteria were co-cultured with DCs in a ratio 100:1. After
stimulation, DCs were stained with ﬂuorochrome-labeled anti-mouse antibodies:
MHC-II–FITC (BD Biosciences), CD86-PE (eBioscience), CD40-PE-Cy7
(BioLegend) and CD11C-APC (BD Biosciences) for 30min at 4 C. Cells were
analysed by ﬂow cytometry (FACSCanto II). For monocytes stimulation, human
THP-1 cells (1 106 cells per ml) were stimulated with bacteria or PBS for 14 h as
described above, but in bacteria to cells ratios of 5:1 and 1:1. After stimulation,
THP-1 cells were stained with CD54-PE (BD Biosciences) for 30min at 4 C and
analysed by ﬂow cytometry. The supernatants of stimulated DCs were collected
and analysed for IL-6, IL-10, IL-12p40 and TNF-a cytokine production by
multiplex bead array (Cytolab AG, Switzerland).
Statistical analysis. Results are presented as mean±s.e.m. unless speciﬁed.
Difference between groups was analysed by unpaired Student’s t-test (two-tailed)
and one-way analysis of variance (ANOVA) with Bonferroni’s multiple
comparison post-test using GraphPad Prism 5. P values below 0.05 were
considered signiﬁcant.
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